EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. 1350 AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 10-K for the fiscal year ended September 30, 2022, of Pharmagreen Biotech Inc, a Nevada corporation (the “Company”), as filed with the Securities and Exchange Commission on the date hereof (the “Annual Report”), we, Peter Wojcik, Principle Executive Officer of the Company and Terry Kwan, Principal Financial Officer of the Company certify, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.	The Annual Report fully complies with the requirements of Section 13(a) or15(d) of the Securities and Exchange Act of 1934, as amended; and
2.	The information contained in this Annual Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

January 16, 2023
/s/ Peter Wojcik
Peter Wojcik
President and Director Principal Executive Officer
/s/ Terry Kwan
Terry Kwan Principal Accounting Officer